IRIS
BIANCHERI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 815
EU - Europa 529
AS - Asia 483
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 808
CN - Cina 451
IE - Irlanda 205
FI - Finlandia 94
UA - Ucraina 69
DE - Germania 61
SE - Svezia 31
SG - Singapore 28
GB - Regno Unito 26
IT - Italia 20
BE - Belgio 12
CA - Canada 7
FR - Francia 5
AU - Australia 3
IN - India 2
NL - Olanda 2
BR - Brasile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
IR - Iran 1
LV - Lettonia 1
MA - Marocco 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.834
Salva come PNG Salva come JPEG
Città #
Chandler 209
Dublin 203
Jacksonville 126
Nanjing 121
Ann Arbor 57
Beijing 53
Boardman 50
Nanchang 48
Ashburn 42
Changsha 42
Shenyang 37
Hebei 36
Lawrence 36
Princeton 36
Wilmington 34
Jiaxing 30
Helsinki 26
Tianjin 21
Shanghai 20
Hangzhou 18
Medford 17
Dearborn 15
Singapore 15
Brussels 12
Milan 11
Fairfield 7
Toronto 6
Woodbridge 6
Norwalk 4
Berlin 3
Jinan 3
Kunming 3
Los Angeles 3
San Francisco 3
Verona 3
Canberra 2
Dallas 2
Des Moines 2
Falkenstein 2
Frankfurt am Main 2
New York 2
Pune 2
Seattle 2
Taizhou 2
Bloomfield 1
Guangzhou 1
Haikou 1
Harbin 1
Hefei 1
Houston 1
Lanzhou 1
London 1
Melbourne 1
Ningbo 1
Pavia 1
Prague 1
Quito 1
Rabat 1
Rome 1
Sassari 1
São Paulo 1
Tappahannock 1
Walnut 1
Yurga 1
Zhengzhou 1
Totale 1.395
Salva come PNG Salva come JPEG
Nome #
Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease. 88
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease. 87
Abnormal anandamide metabolism in celiac disease. 87
Effect of tumor necrosis factor-alpha blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease 78
Splenic hypofunction in whipple's disease. 67
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. 66
Impairment of splenic IgM-memory but not switched-memory B cells in a patient with celiac disease and splenic atrophy. 66
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease 65
Fibroblast activation protein expression in Crohn's disease strictures 64
Absence of a role for interleukin-13 in inflammatory bowel disease 60
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease. 60
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. 58
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. 57
New pathogenic paradigms in inflammatory bowel disease. 56
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. 54
Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab. 54
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. 54
Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab. 51
Detection of Mycobacterium avium subsp. paratuberculosis (MAP)-specific IS900 DNA and antibodies against MAP peptides and lysate in the blood of Crohn's disease patients. 48
Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn’s disease patients treated with infliximab 47
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. 47
Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease. 47
In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts 47
The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut 46
Impairment of splenic IgM-memory but not switched-memory B cells in a patient with celiac disease and splenic atrophy. 45
Innate and adaptive immunity in inflammatory bowel disease 44
Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients with Inflammatory Bowel Disease 42
Proteases and the gut barrier. 41
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 40
Distribution, proliferation, and function of Paneth cells in uncomplicated and complicated adult celiac disease. 40
Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition. 40
Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial 40
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis 33
Low serum levels of microRNA-19 are associated with a stricturing Crohn's disease phenotype 33
Recent advances in understanding ulcerative colitis. 30
Proteases and small intestinal barrier function in health and disease 25
Totale 1.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020135 0 0 0 0 0 25 7 23 3 50 26 1
2020/2021166 16 13 6 15 0 18 1 36 6 28 22 5
2021/2022136 2 3 0 1 4 0 1 11 9 2 25 78
2022/2023571 79 59 3 47 54 52 0 33 232 2 7 3
2023/2024155 24 51 1 7 10 37 3 8 1 8 5 0
2024/202590 6 42 13 15 3 11 0 0 0 0 0 0
Totale 1.907